U-Chart Analysis:KYORIN Pharmaceutical Co., Ltd.:4569

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KYORIN Pharmaceutical Co., Ltd. Go to web site 4569 Medicals 東証プライム March 1, 2000 2006.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KYORIN Pharmaceutical Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 19,394 26,994 27,445 31,925 32,007
Other Current AssetsHelp 99,636 89,382 86,582 85,133 82,897
Tangible Fixed AssetsHelp 25,834 24,334 23,896 22,721 21,792
Intangible Fixed AssetHelp 5,393 3,289 3,785 3,332 3,401
Investments and OthersHelp 25,788 27,925 25,418 28,049 32,937
Total AssetsHelp 176,045 171,924 167,126 171,160 173,034
Total Current LiabilitiesHelp 39,741 36,240 31,020 47,912 49,263
Total Long-term LiabilitiesHelp 10,843 11,177 11,445 538 376
Shareholder's EquityHelp 125,461 124,507 124,661 122,710 123,395
Total LiabilitiesHelp 176,045 171,924 167,126 171,160 173,034

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 113,270 105,534 102,904 109,983 113,620
Total Sales 113,270 105,534 102,904 109,983 113,620
Cost of SalesHelp 63,102 56,093 51,276 52,950 56,210
Other Costs and RevenueHelp 45,444 45,509 45,498 50,884 50,541
Total CostsHelp 108,546 101,602 96,774 103,834 106,751
Net RevenueHelp 50,168 49,441 51,628 57,033 57,410
Earnings Before TaxHelp 6,906 5,216 8,352 8,255 9,359
Net IncomeHelp 4,724 3,932 6,130 6,149 6,869
Net Income 4,724 3,932 6,130 6,149 6,869

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 1,924 6,347 5,187 7,678 341
Investing Cash Flow(ICF)Help -6,275 -2,560 -4,259 -2,943 14,939
Financing Cash FlowHelp -3,363 -4,112 -4,918 -5,117 -27,315
Exchange Difference of Cash and Cash EquivalentsHelp 241 139 -43 -22 -22
Net Increase and Decrease in Cash and Cash Equivalentsn -7,473 -186 -4,033 -404 -12,057

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KYORIN Pharmaceutical Co., Ltd.

Company where related level is highHelp

SymBio Pharmaceuticals Limited
MIKASA SEIYAKU CO.,LTD.
TSUMURA & CO.
Cyfuse Biomedical K.K.
SAWAI GROUP HOLDINGS Co., Ltd.
Mochida Pharmaceutical Co.,Ltd.
SANTEN PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
DENKA SEIKEN Co.,Ltd.
WAKAMOTO PHARMACEUTICAL CO.,LTD.